Riedinger CJ, Barrington DA, Nagel CI, Khadraoui WK, et al. Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer. Gynecol Oncol 2024;183:78-84.
PMID: 38554477